Ribhi Shawar of FDA
joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss
'FDA regulation of clinical microbiology and AST diagnostic devices'
In this presentation, learn about
some examples of challenges in data presentation/analysis as well as scientific and regulatory process understanding.
Download the presentation to understand more about:
Progress in microbial diagnostics, including AMR
Highlights of efforts and initiatives
Efforts on coordinated development between CDRH and CDER
The joint interagency FDA/CDC: Antimicrobial-Resistant Isolates Bank
Curated Genomic Sequence Debates
Get your copy here!
To find out more about
progress in AMR diagnostics and the efforts of the FDA against AMR
World Anti-Microbial Resistance Congress USA 2016
Remember my details
Privacy statement »
Manage your email preferences »
You will be emailed the document as an attachment (2,800Kb in size)